QUADRANT CAPITAL GROUP LLC - Astellas Pharma Inc ownership

Astellas Pharma Inc's ticker is ALPMY and the CUSIP is 04623U102. A total of 10 filers reported holding Astellas Pharma Inc in Q2 2016. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
QUADRANT CAPITAL GROUP LLC ownership history of Astellas Pharma Inc
ValueSharesWeighting
Q4 2019$295,000
+37.9%
18,178
+15.8%
0.04%
+9.1%
Q3 2019$214,000
+2.4%
15,694
+2.7%
0.03%0.0%
Q2 2019$209,000
-48.6%
15,275
-44.6%
0.03%
-54.2%
Q1 2019$407,000
+92.9%
27,557
+57.2%
0.07%
+28.6%
Q4 2018$211,000
+77.3%
17,528
+132.3%
0.06%
+64.7%
Q3 2018$119,000
+30.8%
7,546
+15.4%
0.03%
+6.2%
Q2 2018$91,000
+23.0%
6,539
+25.8%
0.03%
+18.5%
Q1 2018$74,000
+722.2%
5,198
+395.5%
0.03%
+575.0%
Q4 2017$9,0000.0%1,049
+7.9%
0.00%0.0%
Q3 2017$9,000
+350.0%
972
+41.5%
0.00%
+300.0%
Q2 2017$2,000
-94.9%
687
-80.0%
0.00%
-94.1%
Q1 2017$39,000
-4.9%
3,429
+4.1%
0.02%
-19.0%
Q4 2016$41,000
-16.3%
3,293
-4.4%
0.02%
-34.4%
Q3 2016$49,000
+28.9%
3,443
+27.2%
0.03%
+23.1%
Q2 2016$38,000
+11.8%
2,706
-8.2%
0.03%
+18.2%
Q1 2016$34,000
+100.0%
2,949
+116.5%
0.02%
+83.3%
Q4 2015$17,000
+1600.0%
1,362
+1074.1%
0.01%
+1100.0%
Q3 2015$1,0000.0%1160.0%0.00%0.0%
Q2 2015$1,0001160.00%
Other shareholders
Astellas Pharma Inc shareholders Q2 2016
NameSharesValueWeighting ↓
RENAISSANCE GROUP LLC 391,745$5,438,8800.25%
Cassady Schiller Wealth Management, LLC 698$9,6670.01%
MAI Capital Management 19,087$264,3620.00%
SVB WEALTH LLC 10,472$145,0370.00%
RHUMBLINE ADVISERS 34,759$481,4080.00%
First Horizon Advisors, Inc. 114$1,5780.00%
Operose Advisors LLC 90$1,2470.00%
Russell Investments Group, Ltd. 783$10,8450.00%
PNC FINANCIAL SERVICES GROUP, INC. 166$2,2990.00%
View complete list of Astellas Pharma Inc shareholders